First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT) Sees Unusually-High Trading Volume – Time to Buy?

First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT) shares saw strong trading volume on Monday . 52,210 shares traded hands during trading, an increase of 83% from the previous session’s volume of 28,506 shares.The stock last traded at $180.98 and had previously closed at $179.35.

First Trust NYSE Arca Biotechnology Index Fund Trading Up 0.7 %

The firm has a market cap of $1.36 billion, a P/E ratio of 17.20 and a beta of 0.86. The company’s 50-day moving average is $171.56 and its two-hundred day moving average is $169.81.

Institutional Investors Weigh In On First Trust NYSE Arca Biotechnology Index Fund

A number of hedge funds have recently made changes to their positions in the business. Dominguez Wealth Management Solutions Inc. bought a new position in First Trust NYSE Arca Biotechnology Index Fund during the third quarter valued at $201,000. Blue Trust Inc. lifted its position in shares of First Trust NYSE Arca Biotechnology Index Fund by 3,248.6% during the 3rd quarter. Blue Trust Inc. now owns 1,172 shares of the company’s stock valued at $202,000 after buying an additional 1,137 shares during the last quarter. J.W. Cole Advisors Inc. bought a new position in shares of First Trust NYSE Arca Biotechnology Index Fund during the 3rd quarter worth $203,000. Synovus Financial Corp purchased a new stake in First Trust NYSE Arca Biotechnology Index Fund in the 3rd quarter worth about $203,000. Finally, Wharton Business Group LLC bought a new stake in First Trust NYSE Arca Biotechnology Index Fund in the 3rd quarter valued at about $206,000.

First Trust NYSE Arca Biotechnology Index Fund Company Profile

The First Trust NYSE Arca Biotechnology Index Fund (FBT) is an exchange-traded fund that is based on the NYSE Arca Biotechnology index. The fund tracks an equal-weighted index of US biotechnology stocks. FBT was launched on Jun 19, 2006 and is managed by First Trust.